New combo pill tested against standard diabetes meds in healthy adults
NCT ID NCT07102719
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a new tablet (HD-P023) against taking two diabetes drugs separately in 40 healthy adults. Researchers measured how the drugs move through the body and checked for safety. The goal was to see if the combination pill works similarly to the separate medicines.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
H Plus Yangji Hospital
Seoul, 08779, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug pass its first safety hurdle?
- Can a new drug play nice with common medicines? a trial investigates
- Could a new pill quiet chronic pain? early trial puts it to the test
- Brain waves under pressure: can light uncover the signature of mental work?
- Can acting as patients teach nurses to truly listen?
- Who decides for you? survey asks incarcerated older adults